Transdiagnostic Cognitive-behavioral Therapy for Patients with Eating Disorders: a Two-site Trial with 60-week Follow-up
Overview
Authors
Affiliations
Objective: The aim of this study was to compare two cognitive-behavioral treatments for outpatients with eating disorders, one focusing solely on eating disorder features and the other a more complex treatment that also addresses mood intolerance, clinical perfectionism, low self-esteem, or interpersonal difficulties.
Method: A total of 154 patients who had a DSM-IV eating disorder but were not markedly underweight (body mass index over 17.5), were enrolled in a two-site randomized controlled trial involving 20 weeks of treatment and a 60-week closed period of follow-up. The control condition was an 8-week waiting list period preceding treatment. Outcomes were measured by independent assessors who were blind to treatment condition.
Results: Patients in the waiting list control condition exhibited little change in symptom severity, whereas those in the two treatment conditions exhibited substantial and equivalent change, which was well maintained during follow-up. At the 60-week follow-up assessment, 51.3% of the sample had a level of eating disorder features less than one standard deviation above the community mean. Treatment outcome did not depend on eating disorder diagnosis. Patients with marked mood intolerance, clinical perfectionism, low self-esteem, or interpersonal difficulties appeared to respond better to the more complex treatment, with the reverse pattern evident among the remaining patients.
Conclusions: These two transdiagnostic treatments appear to be suitable for the majority of outpatients with an eating disorder. The simpler treatment may best be viewed as the default version, with the more complex treatment reserved for patients with marked additional psychopathology of the type targeted by the treatment.
Mindfulness-based interventions for binge eating: an updated systematic review and meta-analysis.
Liu J, Tynan M, Mouangue A, Martin C, Manasse S, Godfrey K J Behav Med. 2025; 48(1):57-89.
PMID: 39979674 PMC: 11893636. DOI: 10.1007/s10865-025-00550-5.
Schmidt U, Claudino A, Fernandez-Aranda F, Giel K, Griffiths J, Hay P World Psychiatry. 2025; 24(1):4-31.
PMID: 39810680 PMC: 11733474. DOI: 10.1002/wps.21263.
Liu J, Giannone A, Wang H, Wetherall L, Juarascio A JMIR Form Res. 2024; 8():e60865.
PMID: 39556809 PMC: 11612586. DOI: 10.2196/60865.
Understanding the phenomenological experiences of schema therapy for those with an eating disorder.
Cunningham A, Reid M, Sayan S, Hammersley R Qual Res Med Healthc. 2024; 8(2):11376.
PMID: 39360015 PMC: 11445698. DOI: 10.4081/qrmh.2024.11376.
Hassan Kariri H, Almubaddel A Heliyon. 2024; 10(18):e37763.
PMID: 39323855 PMC: 11422574. DOI: 10.1016/j.heliyon.2024.e37763.